After reading this board, there is every viewpoint from a stock underpriced and ready to explode, to an overpriced stock that has produced nothing of any value with safety concerns. So, what is one to believe?
$150, would love to see it but thinking that is reaching a bit. $100 at 4Q and i'll be content
Been a fan of Stan for 10 years
Don't listen to those who would seek to mislead you. ISIS drugs are safe as proven during the clinical trials.
Plus they just posted a profit.
That short position is killing them, that's why they lie.
This is only the beginning. In 2018 I even cannot imagine how high we will go - possibly over 400$.
isis for 27 years always had more of everything and in the end had nothing each time. Ck Barron's in 2000 exposing isis. Keep pumping pipelines and toxic isis drugs. Who is going to take them into their body after toxic poison invades healthy tissue? isis is one liver, one cancer, one bone marrow from a plunge you will never forget!!! Hedge funds are fully hedged !!
Sentiment: Strong Sell
I own both of them, and ALNY has a 400 mill higher valuation than ISIS. Now, don't tell the ALNY board this, but if ALNY deserves an 8.5 billion valuation, then ISIS deserves double that. ALNY has 15 named drugs in development, with one phase 3, one phase 1 1/2, and the rest are phase 1 or earlier. Now go take a look at what ISIS has in their pipeline. More than 2X the drugs, two approved, five drugs in phase 3, 12 in phase 2, and a whopping 15 more in phase 1 or preclinical. But wait, you're not done yet! NOW go look at the market size of just three of ISIS's drugs: ISIS-APOCIIIRx, ISIS-FXIRx, ISIS-ANGPTL3Rx. The only reason I can think of as to why ISIS has not yet been acquired, is a) too many partnerships with other competing companies to the acquirer, and/or b) people want to see more RNAi drugs approved before they buy the platform.
Like it! I was closer to 200 in my evaluation or close.... JAZZ paid a buck in 2009, look now....
Sentiment: Strong Buy
I'm not bashing, I own this stock. I'm just telling it like it is. I expected better, much better results than this. I think we might see a different story on Monday. It's Friday folks
AT $8B in MKT CAP at the moment its just about fully valued
So when it heads for $70 PPS its going to sell-off until we build a new floor and have a pipeline/partnership catalyst that adds some significant value